STAT6 and depressive symptom measurement: Upon further validation using groups treated with an IL‐4 inhibitor and a p‐STAT6 inhibitor, we observed that the level of IL‐4 in IBD model mice exhibiting depression significantly decreased, whereas neuroinflammation did not show improvement.